Andy Upsall is the founder and CEO of RoukenBio, a customer-centric organization focused on scientific innovation in the biotechnology sector. With a commitment to scientific excellence, RoukenBio supports early-stage drug development, offering reliable and innovative solutions tailored to client needs. Prior to founding RoukenBio in 2015, Andy Upsall co-founded BioOutsource Ltd, serving as Director of R&D until its acquisition by Sartorius Stedim Biotech in 2015, and held positions as Study Director at Covance and QC Virologist at MedImmune Vaccines. Andy’s leadership is characterized by a dedication to forming strong partnerships with respected biotech companies to advance novel therapeutics from discovery to clinical development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices